Artificial Pancreas Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021

Pages: 103 Published: June 15, 2021 Report Code: GDME1124EPD

  • Overview
  • Key Players
  • Contents
  • Tables
  • Figures
  • Listen
    iSpeech

Artificial Pancreas helps people with diabetes, primarily type 1, automatically and continuously control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas. GlobalData's Medical Devices sector report, "Artificial Pancreas – Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Artificial Pancreas pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Artificial Pancreas Pipeline Landscape report provides key information and data related to:

Extensive coverage of the Artificial Pancreas under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Artificial Pancreas pipeline products.

Review of Recent Developments in the segment / industry

The Artificial Pancreas Pipeline Landscape report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

Identify and understand important and diverse types of Glaucoma Drainage Device sunder development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

The major companies covered in the “Artificial Pancreas – Medical Devices Pipeline Product Landscape, 2021” report:

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

Extensive coverage of the Artificial Pancreas under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Artificial Pancreas and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

Identify and understand important and diverse types of Artificial Pancreas under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Players

Admetsys Corp

Advanced Biosensors-Ohio LLC

Beta Bionics Inc

Beta-O2 Technologies Ltd

Bigfoot Biomedical Inc

BioTex Inc

Cerco Medical LLC

Converge Biotech, Inc.

Covalor Medical, LLC

De Montfort University

Debiotech SA

Defymed SAS

Diabeloop SA

EOFlow Co Ltd

Giner Inc

Harvard John A Paulson School of Engineering and Applied Sciences

Healios Inc

Humacyte Inc

Ideal Medical Technologies Inc

Imperial College London

Inreda Diabetic BV

Insulet Corp

Joslin Diabetes Center

Kencak LLC

McGill University

Medtronic Diabetes

Medtronic Inc

Miromatrix Medical Inc

Pacific Diabetes Technologies, Inc.

Pancreum, LLC

PharmaCyte Biotech Inc

Polytechnic University of Valencia

Rensselaer Polytechnic Institute

Senseonics Holdings Inc

Stanford University

TecMed Inc

The Alfred Mann Foundation

TypeZero Technologies LLC

U-Needle BV

Universidad Autonoma de Madrid

University of California San Francisco

University of California Santa Barbara

University of Cambridge

University of Florida

University of Minnesota

University of Newcastle

WaveForm Technologies Inc

XERIS Pharmaceuticals Inc

Yale University

Table of Contents

1 Table of Contents 3

1.1 List of Tables 6

1.2 List of Figures 10

2 Introduction 11

2.1 Artificial Pancreas Overview 11

3 Products under Development 12

3.1 Artificial Pancreas – Pipeline Products by Stage of Development 12

3.2 Artificial Pancreas – Pipeline Products by Territory 13

3.3 Artificial Pancreas – Pipeline Products by Regulatory Path 14

3.4 Artificial Pancreas – Pipeline Products by Estimated Approval Date 15

3.5 Artificial Pancreas – Ongoing Clinical Trials 16

4 Artificial Pancreas – Pipeline Products under Development by Companies 17

4.1 Artificial Pancreas Companies – Pipeline Products by Stage of Development 17

4.2 Artificial Pancreas – Pipeline Products by Stage of Development 19

5 Artificial Pancreas Companies and Product Overview 21

5.1 Admetsys Corp Company Overview 21

5.1.1 Admetsys Corp Pipeline Products & Ongoing Clinical Trials Overview 21

5.2 Advanced Biosensors-Ohio LLC Company Overview 22

5.2.1 Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview 22

5.3 Beta Bionics Inc Company Overview 23

5.3.1 Beta Bionics Inc Pipeline Products & Ongoing Clinical Trials Overview 23

5.4 Beta-O2 Technologies Ltd Company Overview 30

5.4.1 Beta-O2 Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

5.5 Bigfoot Biomedical Inc Company Overview 33

5.5.1 Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 33

5.6 BioTex Inc Company Overview 34

5.6.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 34

5.7 Cerco Medical LLC Company Overview 35

5.7.1 Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 35

5.8 Converge Biotech, Inc. Company Overview 36

5.8.1 Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36

5.9 Covalor Medical, LLC Company Overview 37

5.9.1 Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 37

5.10 De Montfort University Company Overview 38

5.10.1 De Montfort University Pipeline Products & Ongoing Clinical Trials Overview 38

5.11 Debiotech SA Company Overview 39

5.11.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 39

5.12 Defymed SAS Company Overview 40

5.12.1 Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview 40

5.13 Diabeloop SA Company Overview 41

5.13.1 Diabeloop SA Pipeline Products & Ongoing Clinical Trials Overview 41

5.14 EOFlow Co Ltd Company Overview 46

5.14.1 EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

5.15 Giner Inc Company Overview 48

5.15.1 Giner Inc Pipeline Products & Ongoing Clinical Trials Overview 48

5.16 Harvard John A Paulson School of Engineering and Applied Sciences Company Overview 49

5.16.1 Harvard John A Paulson School of Engineering and Applied Sciences Pipeline Products & Ongoing Clinical Trials Overview 49

5.17 Healios Inc Company Overview 52

5.17.1 Healios Inc Pipeline Products & Ongoing Clinical Trials Overview 52

5.18 Humacyte Inc Company Overview 53

5.18.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 53

5.19 Ideal Medical Technologies Inc Company Overview 54

5.19.1 Ideal Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 54

5.20 Imperial College London Company Overview 55

5.20.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 55

5.21 Inreda Diabetic BV Company Overview 56

5.21.1 Inreda Diabetic BV Pipeline Products & Ongoing Clinical Trials Overview 56

5.22 Insulet Corp Company Overview 57

5.22.1 Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview 57

5.23 Joslin Diabetes Center Company Overview 61

5.23.1 Joslin Diabetes Center Pipeline Products & Ongoing Clinical Trials Overview 61

5.24 Kencak LLC Company Overview 62

5.24.1 Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview 62

5.25 McGill University Company Overview 63

5.25.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview 63

5.26 Medtronic Diabetes Company Overview 64

5.26.1 Medtronic Diabetes Pipeline Products & Ongoing Clinical Trials Overview 64

5.27 Medtronic Inc Company Overview 69

5.27.1 Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview 69

5.28 Miromatrix Medical Inc Company Overview 70

5.28.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 70

5.29 Pacific Diabetes Technologies, Inc. Company Overview 71

5.29.1 Pacific Diabetes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71

5.30 Pancreum, LLC Company Overview 72

5.30.1 Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview 72

5.31 PharmaCyte Biotech Inc Company Overview 73

5.31.1 PharmaCyte Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 73

5.32 Polytechnic University of Valencia Company Overview 74

5.32.1 Polytechnic University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 74

5.33 Rensselaer Polytechnic Institute Company Overview 75

5.33.1 Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 75

5.34 Senseonics Holdings Inc Company Overview 78

5.34.1 Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 78

5.35 Stanford University Company Overview 79

5.35.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 79

5.36 TecMed Inc Company Overview 80

5.36.1 TecMed Inc Pipeline Products & Ongoing Clinical Trials Overview 80

5.37 The Alfred Mann Foundation Company Overview 81

5.37.1 The Alfred Mann Foundation Pipeline Products & Ongoing Clinical Trials Overview 81

5.38 TypeZero Technologies LLC Company Overview 82

5.38.1 TypeZero Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 82

5.39 U-Needle BV Company Overview 83

5.39.1 U-Needle BV Pipeline Products & Ongoing Clinical Trials Overview 83

5.40 Universidad Autonoma de Madrid Company Overview 84

5.40.1 Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview 84

5.41 University of California San Francisco Company Overview 85

5.41.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 85

5.42 University of California Santa Barbara Company Overview 86

5.42.1 University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 86

5.43 University of Cambridge Company Overview 88

5.43.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 88

5.44 University of Florida Company Overview 90

5.44.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 90

5.45 University of Minnesota Company Overview 91

5.45.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 91

5.46 University of Newcastle Company Overview 92

5.46.1 University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview 92

5.47 WaveForm Technologies Inc Company Overview 93

5.47.1 WaveForm Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 93

5.48 XERIS Pharmaceuticals Inc Company Overview 94

5.48.1 XERIS Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 94

5.49 Yale University Company Overview 95

5.49.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 95

6 Artificial Pancreas – Recent Developments 96

6.1 May 06, 2021: Insulet Reports First Quarter 2021 Revenue Increase of 27% Year-Over-Year 96

6.2 May 05, 2021: University of Cambridge appoints Dr Diarmuid O’Brien as new Chief Executive of Cambridge Enterprise 97

6.3 Apr 05, 2021: Insulet to Announce First Quarter 2021 Financial Results on May 6, 2021 98

6.4 Mar 02, 2021: Xeris Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call and Webcast on March 9, 2021 98

6.5 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021 98

6.6 Nov 09, 2020: Xeris Pharmaceuticals to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 9, 2020 99

6.7 Aug 06, 2020: Insulet to Announce Second Quarter 2020 Financial Results on August 6, 2020 99

7 Appendix 100

7.1 Methodology 100

7.2 About GlobalData 103

7.3 Contact Us 103

7.4 Disclaimer 103

List of Tables

Artificial Pancreas – Pipeline Products by Stage of Development 12

Artificial Pancreas – Pipeline Products by Territory 13

Artificial Pancreas – Pipeline Products by Regulatory Path 14

Artificial Pancreas – Pipeline Products by Estimated Approval Date 15

Artificial Pancreas – Ongoing Clinical Trials 16

Artificial Pancreas Companies – Pipeline Products by Stage of Development 17

Artificial Pancreas – Pipeline Products by Stage of Development 19

Admetsys Corp Pipeline Products & Ongoing Clinical Trials Overview 21

Smart Pancreas – Product Status 21

Smart Pancreas – Product Description 21

Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview 22

Artificial Pancreas – Product Status 22

Artificial Pancreas – Product Description 22

Beta Bionics Inc Pipeline Products & Ongoing Clinical Trials Overview 23

Bihormonal iLet Bionic Pancreas – Product Status 23

Bihormonal iLet Bionic Pancreas – Product Description 23

Gen 2 GlucoSTAT – Product Status 24

Gen 2 GlucoSTAT – Product Description 24

Gen 4 iLet System – Product Status 24

Gen 4 iLet System – Product Description 25

iLet Bionic Pancreas – Glucagon-only – Product Status 25

iLet Bionic Pancreas – Glucagon-only – Product Description 25

iLet Bionic Pancreas – Insulin-only – Product Status 26

iLet Bionic Pancreas – Insulin-only – Product Description 26

Beta Bionics Inc – Ongoing Clinical Trials Overview 27

Bihormonal iLet Bionic Pancreas – Feasibility of Outpatient Automated Blood Glucose Control with the iLet Bionic Pancreas for Treatment of Cystic Fibrosis Related Diabetes 28

iLet Bionic Pancreas – Insulin-only – Feasibility of Outpatient Automated Blood Glucose Control with the iLet Bionic Pancreas for Treatment of Cystic Fibrosis Related Diabetes 29

iLet Bionic Pancreas – Insulin-only – Individualizing Automated Closed Loop Glucose Control through Pharmacokinetic Profiling in an Insulin-only Bionic Pancreas 29

iLet Bionic Pancreas – Insulin-only – The Insulin-only Bionic Pancreas Pivotal Trial: Testing the iLet in Adults and Children with Type 1 Diabetes 29

Beta-O2 Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

ßAir Bio-artificial Pancreas – Product Status 30

ßAir Bio-artificial Pancreas – Product Description 30

Beta-O2 Technologies Ltd – Ongoing Clinical Trials Overview 31

ßAir Bio-artificial Pancreas – An Open Label, Pilot Investigation, to Assess the Safety and Efficacy of Transplantation of Macro-encapsulated Human Islets within the Bioartificial Pancreas Beta-air in Patients with Type 1 Diabetes Mellitus 32

Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 33

Bigfoot Smartloop System – Product Status 33

Bigfoot Smartloop System – Product Description 33

BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 34

Artificial Pancreas – Product Status 34

Artificial Pancreas – Product Description 34

Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 35

Bioartificial Pancreas – Product Status 35

Bioartificial Pancreas – Product Description 35

Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36

Bioartificial Pancreas System – Product Status 36

Bioartificial Pancreas System – Product Description 36

Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 37

Artificial Pancreas – Product Status 37

Artificial Pancreas – Product Description 37

De Montfort University Pipeline Products & Ongoing Clinical Trials Overview 38

InSmart Artificial Pancreas – Product Status 38

InSmart Artificial Pancreas – Product Description 38

Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 39

Next Generation Artificial Pancreas – Product Status 39

Next Generation Artificial Pancreas – Product Description 39

Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview 40

MAILPAN – Product Status 40

MAILPAN – Product Description 40

Diabeloop SA Pipeline Products & Ongoing Clinical Trials Overview 41

DBL-hu – Product Status 41

DBL-hu – Product Description 41

DBLG1 – Adults – Product Status 42

DBLG1 – Adults – Product Description 42

DBLG1 – Pediatric Version – Product Status 42

DBLG1 – Pediatric Version – Product Description 43

Diabeloop SA – Ongoing Clinical Trials Overview 44

DBLG1 – Adults – Observational Study of the Use of DBLG1 System in Real Life 45

EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

EOPancreas – Product Status 46

EOPancreas – Product Description 46

EOPatchX – Product Status 47

EOPatchX – Product Description 47

Giner Inc Pipeline Products & Ongoing Clinical Trials Overview 48

BAPIOS System – Product Status 48

BAPIOS System – Product Description 48

Harvard John A Paulson School of Engineering and Applied Sciences Pipeline Products & Ongoing Clinical Trials Overview 49

Pregnancy-Specific Artificial Pancreas – Product Status 49

Pregnancy-Specific Artificial Pancreas – Product Description 49

Harvard John A Paulson School of Engineering and Applied Sciences – Ongoing Clinical Trials Overview 50

Pregnancy-Specific Artificial Pancreas – Observational Study of Patient Important Outcomes in Pregnant Patients with Type 1 Diabetes Mellitus on Insulin Pump 51

Healios Inc Pipeline Products & Ongoing Clinical Trials Overview 52

Bioengineered Pancreas – Product Status 52

Bioengineered Pancreas – Product Description 52

Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 53

BioVascular Pancreas – Product Status 53

BioVascular Pancreas – Product Description 53

Ideal Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 54

FUSION System – Product Status 54

FUSION System – Product Description 54

Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 55

Bio-inspired Artificial Pancreas – Product Status 55

Bio-inspired Artificial Pancreas – Product Description 55

Inreda Diabetic BV Pipeline Products & Ongoing Clinical Trials Overview 56

Bi-Hormonal Artificial Pancreas – Lighter Version – Product Status 56

Bi-Hormonal Artificial Pancreas – Lighter Version – Product Description 56

Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview 57

Omnipod 5 – Product Status 57

Omnipod 5 – Product Description 57

Insulet Corp – Ongoing Clinical Trials Overview 58

Omnipod 5 – Automated Insulin Delivery for Inpatients with DysGlycemia (AIDING) Feasibility Study 59

Omnipod 5 – Evaluating the Safety and Effectiveness of the Omnipod 5 Automated Insulin Delivery System in Patients with Type 2 Diabetes 59

Omnipod 5 – Evaluating the Safety and Effectiveness of the Omnipod Horizon Automated Glucose Control System in Children with Type 1 Diabetes Aged 2.0-5.9 Years: Preschool Cohort 59

Omnipod 5 – Evaluating the Safety and Effectiveness of the Omnipod Horizon Automated Glucose Control System in Patients with Type 1 Diabetes 60

Joslin Diabetes Center Pipeline Products & Ongoing Clinical Trials Overview 61

Closed-Loop Glucagon Delivery System – Product Status 61

Closed-Loop Glucagon Delivery System – Product Description 61

Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview 62

BioArtificial Pancreas – Product Status 62

BioArtificial Pancreas – Product Description 62

McGill University Pipeline Products & Ongoing Clinical Trials Overview 63

Artificial Pancreas – Type 1 Diabetes – Product Status 63

Artificial Pancreas – Type 1 Diabetes – Product Description 63

Medtronic Diabetes Pipeline Products & Ongoing Clinical Trials Overview 64

Minimed 780G – Adults – Product Status 64

Minimed 780G – Adults – Product Description 64

Minimed 890G – Product Status 65

Minimed 890G – Product Description 65

Medtronic Diabetes – Ongoing Clinical Trials Overview 66

Minimed 780G – Adults – Advanced Hybrid Closed-Loop Treatment in Adults with Type 1 Diabetes Not Meeting Glycaemic Targets: A Randomized Controlled Trial – The Steno 780G Study 67

Minimed 780G – Adults – An 8-day Initiation Protocol of Advanced Hybrid Closed Loop System in Children and Adolescents with Diabetes Type 1 on Multiple Daily Insulin Injection 67

Minimed 780G – Adults – Closed-loop Insulin Delivery in Pregnant Women with Type 1 Diabetes: A Randomized Controlled Trial: The CRISTAL Study 67

Minimed 780G – Adults – Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects 68

Minimed 780G – Adults – The MiniMed 780G Glycemic Control and Quality of Life Study for the Treatment of Pediatric and Adult Subjects with Type 1 Diabetes in France: EQOL Study 68

Minimed 780G – Adults – Transition of Patients with T1D From Multiple Daily Injection (MDI) and Self-monitoring of Blood Glucose (SMBG) Directly to MiniMed 780G Advanced Hybrid Closed Loop (AHCL) System :Impact on Glucose Control and Quality of Life Measures 68

Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview 69

Third-Generation Artificial Pancreas System – Product Status 69

Third-Generation Artificial Pancreas System – Product Description 69

Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 70

Miro Pancreas – Product Status 70

Miro Pancreas – Product Description 70

Pacific Diabetes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71

SynerG – Product Status 71

SynerG – Product Description 71

Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview 72

Genesis Artificial Pancreas – Product Status 72

Genesis Artificial Pancreas – Product Description 72

PharmaCyte Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 73

Bio-Artificial Pancreas – Product Status 73

Bio-Artificial Pancreas – Product Description 73

Polytechnic University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 74

ClosedLoop 4Meal – Product Status 74

ClosedLoop 4Meal – Product Description 74

Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 75

Closed-Loop Artificial Pancreas System – Product Status 75

Closed-Loop Artificial Pancreas System – Product Description 75

Rensselaer Polytechnic Institute – Ongoing Clinical Trials Overview 76

Closed-Loop Artificial Pancreas System – Restoring Brain Metabolism and Function in Older Adult T1DM Patients Using an AP System 77

Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 78

Eversense CGM System Integrated With inControl And Accu-Chek Insight Insulin Pump – Product Status 78

Eversense CGM System Integrated With inControl And Accu-Chek Insight Insulin Pump – Product Description 78

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 79

Artificial Pancreas Device – Product Status 79

Artificial Pancreas Device – Product Description 79

TecMed Inc Pipeline Products & Ongoing Clinical Trials Overview 80

Artificial Pancreas – Product Status 80

Artificial Pancreas – Product Description 80

The Alfred Mann Foundation Pipeline Products & Ongoing Clinical Trials Overview 81

Implantable Artificial Pancreas Device – Product Status 81

Implantable Artificial Pancreas Device – Product Description 81

TypeZero Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 82

inControl – Product Status 82

inControl – Product Description 82

U-Needle BV Pipeline Products & Ongoing Clinical Trials Overview 83

Microneedle Artificial Pancreas – Product Status 83

Microneedle Artificial Pancreas – Product Description 83

Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview 84

Predictive Rule-Based Algorithm – Product Status 84

Predictive Rule-Based Algorithm – Product Description 84

University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 85

Implantable Bioartificial Pancreas – Product Status 85

Implantable Bioartificial Pancreas – Product Description 85

University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 86

Closed-Loop Artificial Pancreas – Product Status 86

Closed-Loop Artificial Pancreas – Product Description 86

Pediatric Artificial Pancreas – Product Status 87

Pediatric Artificial Pancreas – Product Description 87

University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 88

Florence D2A System – Product Status 88

Florence D2A System – Product Description 88

FlorenceM – Product Status 89

FlorenceM – Product Description 89

University of Florida Pipeline Products & Ongoing Clinical Trials Overview 90

Bioartificial Pancreas – Type 1 Diabetes – Product Status 90

Bioartificial Pancreas – Type 1 Diabetes – Product Description 90

University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 91

Implantable Microvalve Device – Product Status 91

Implantable Microvalve Device – Product Description 91

University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview 92

Closed Glucose-Sensing Insulin-Delivery System – Product Status 92

Closed Glucose-Sensing Insulin-Delivery System – Product Description 92

WaveForm Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 93

Closed Loop Insulin Delivery Solution – Product Status 93

Closed Loop Insulin Delivery Solution – Product Description 93

XERIS Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 94

Bi-Hormonal Artificial Pancreas – Product Status 94

Bi-Hormonal Artificial Pancreas – Product Description 94

Yale University Pipeline Products & Ongoing Clinical Trials Overview 95

Automated Insulin Delivery System – Product Status 95

Automated Insulin Delivery System – Product Description 95

Glossary 102

List of Figures

Artificial Pancreas – Pipeline Products by Stage of Development 12

Artificial Pancreas – Pipeline Products by Territory 13

Artificial Pancreas – Pipeline Products by Regulatory Path 14

Artificial Pancreas – Pipeline Products by Estimated Approval Date 15

Artificial Pancreas – Ongoing Clinical Trials 16

$4000

Can be used by individual purchaser only

$12000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.